Prudential Financial’s Xilio Therapeutics XLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$119K Buy
+13,180
New +$119K ﹤0.01% 2395

Other funds holding XLO

Prudential Financial's XLO Position: Q3 2026 in Review

Prudential Financial opened a new position in Xilio Therapeutics (XLO) in Q3 2026: 13,180 shares worth $119K. The stake represents ﹤0.01% of the portfolio and ranks #2395 among its holdings.

30 funds tracked by Wall St. Rank hold XLO as of Q3 2026.

  • Prudential Financial held 13,180 shares of Xilio Therapeutics worth $119K as of Q3 2026.
  • Xilio Therapeutics was a new Prudential Financial position in Q3 2026.
  • Xilio Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q3 2026, its #2395 holding.
  • 30 funds tracked by Wall St. Rank held Xilio Therapeutics as of Q3 2026.

Based on Prudential Financial's 13F filing for Q3 2026, filed 16 Nov 2026.